Fingolimod ameliorates schizophrenia‐like cognitive impairments induced by phencyclidine in male rats
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Pharmacology"
DOI: 10.1111/bph.15954
Abstract: Improvement of cognitive deficits in schizophrenia remains an unmet need owing to the lack of new therapies and drugs. Recent studies have reported that fingolimod, an immunomodulatory drug for treating multiple sclerosis, demonstrates anti‐inflammatory and… read more here.
Keywords: impairments induced; ameliorates schizophrenia; fingolimod ameliorates; like cognitive ... See more keywords